has server used (United States) ping response time Hosted in Google LLC Register Domain Names at SN Domains Inc. This domain has been created 10 years, 307 days ago, remaining 58 days. You can check the 9 Websites and blacklist ip address on this server

Domain information

Registrar WHOIS Server:

Registrar URL:     See All 80+

Creation Date: 2011-02-01 10 years, 307 days

Updated Date: 2021-01-25 314 days ago

Expiry Date: 2022-02-01 58 days left     See All

  Sign up for notifications near expiration

Registrar: SN Domains Inc

Abuse Email: n/a

Abuse Phone: n/a

  Full details

Top 10 Hosting Providers

Registrar URLDomain CountsRegistrar NameAbuse Email,280,, LLC[email protected]
www.tucows.com535,579Tucows Domains Inc.
networksolutions.com526,027Network Solutions, LLC[email protected]
www.namecheap.com333,839NameCheap, Inc.[email protected]
www.enom.com299,925eNom, LLC
www.publicdomainregistry.com294,948PDR Ltd. d/b/a[email protected],, LLC[email protected]
www.fastdomain.com161,753FastDomain Inc.[email protected]
www.ionos.com159,2071&1 IONOS SE[email protected]
www.networksolutions.com149,653Network Solutions, LLC[email protected]

Full view & Download

Keywords Suggestions


Bexsero schedule

Bexsero dosing schedule


Bexsero information

Bexsero dosing

Bexsero #2

Bexsero 2

Bexsero ml

Bexsero pi

Bexsero spc

Bexsero dose

Bexsero cvs

Bexsero egg

Bexsero ema

Bexsero emc

Bexsero im

Bexsero nps

Bexsero pdf

Bexsero rcm

Bexsero rcp

Bexsero va

Bexsero age

Bexsero dose schedule

Bexsero package insert pdf

( Please select at least 2 keywords )

See More:   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

› Bexsero and menactra given together

› Bexsero dosing schedule cdc

› Bexsero men b age

› Bexsero dosing schedule

› Bexsero dosing interval

› Bexsero vaccine schedule

› Bexsero information

› Meningitis vaccines

Hosting Provider

NetName: GOOGL-2

Organization: Google LLC     See All 681,421+

Provider URL:


IP Server: Reg: 2018-09-28, Updated: 2018-09-28

Blacklist: Check Backlist Status

Country: United States

Address: 1600 Amphitheatre Parkway, Mountain View, CA 94043, US

Latitude: 29.966801

Longitude: -95.345398

Name Server:


Abuse Email: [email protected]

Abuse Phone: +1-650-253-0000

Top 10 Hosting Providers

Website URLDomain CountsOrganizationAbuse Email
Google.com681,421Google LLC[email protected]
Godaddy.com650,, LLC[email protected]
Cloudflare.com637,900Cloudflare, Inc.[email protected]
Endurance.com488,827The Endurance International Group, Inc.[email protected]
Amazon.com439,891Amazon Technologies Inc.[email protected]
297,405Domain Name Services
Amazonaws.com287,121Amazon Technologies Inc.[email protected]
Liquidweb.com159,971Liquid Web, L.L.C[email protected]
Squarespace.com150,667Squarespace, Inc.[email protected]
Ripe.net128,362RIPE Network Coordination Centre[email protected]

Full view & Download

List of found email addresses

No Emails Found

Find Websites hosted










At least 9 Sites on this server

Port Scanner (IP:

Meningitis B Vaccine BEXSERO

  • BEXSERO is a vaccine approved for 10- through 25-year-olds to prevent meningococcal group B disease (also known as meningitis B) caused by Neisseria meningitidis bacteria
  • Approval of BEXSERO is based on immune response against three group B bacterial strains representative of prevalent strains in the US.   DA: 15 PA: 15 MOZ Rank: 30

Bexsero Injektionssuspension In Einer Fertigspritze

  • chen Bexsero in einer Dosis verabreicht wurde, die ca
  • der zehnfachen Dosis beim Menschen entspricht (bezogen auf das Körpergewicht), ergaben sich keine Hin-weise auf eine maternale oder fetale Toxi-zität und es wurden keine Auswirkungen auf die Schwangerschaft, auf das Verhalten der Muttertiere, die Fertilität der Weibchen   DA: 23 PA: 16 MOZ Rank: 40

Where Can I Get The Bexserro (Meningitus B) Vaccine For My

  • The cost of BEXSERO® may be covered with your private insurance
  • Contact your insurance provider and give the DIN (drug identification number) to find out, DIN: 02417030
  • The vaccine schedule for babies 6-11 months of age is to receive 2 doses 8 weeks apart, with a third dose after 12 months of age (and at least 8 weeks after dose 2).   DA: 13 PA: 50 MOZ Rank: 65

Bexsero X 1 Seringa Preumpluta Cu Ace X 0,5 Ml Suspensie

  • Bexsero conţine clorură de sodiu
  • Acest medicament conţine mai puţin de 1 mmol de sodiu (23 mg) per doză, adică practic „nu conţine sodiu”
  • Bexsero (0,5 ml) vi se va administra dumneavoastră sau copilului dumneavoastră de către un medic sau o asistentă medicală
  • Va fi injectat într-un muşchi, de   DA: 13 PA: 50 MOZ Rank: 66


  • La fel ca în cazul altor vaccinuri, administrarea Bexsero trebuie amânată la subiecţii cu boală febrilă acută severă
  • Cu toate acestea, prezenţa unei infecţii minore, cum ar fi răceala, nu necesită amânarea vaccinării
  • A nu se administra intravascular.   DA: 17 PA: 50 MOZ Rank: 71

Meningococcal B Vaccine (Bexsero®): Q&A For Health Care

  • Meningococcal B Vaccine (Bexsero ®): Q&A for health care providers
  • This questions and answers sheet for health care professionals provides basic information only
  • It is not intended to provide or take the place of medical advice, diagnosis or treatment
  • Effective December 2014, Ontario has introduced the multicomponent meningococcal B vaccine   DA: 20 PA: 50 MOZ Rank: 75

Bexsero Immunisation Advisory Centre

  • Meningococcal disease is caused by the bacterium Neisseria meningitidis
  • At least 12 groups have been identified, including groups A, B, C, X, Y and W
  • The pattern of disease caused by each group varies by time and country or geographical areas
  • In New Zealand over 2014–2017, meningococcal group B caused around two-thirds of   DA: 17 PA: 36 MOZ Rank: 59

Bexsero Prices, Coupons & Savings Tips

  • Bexsero is only available as a brand name drug
  • The lowest GoodRx price for the most common version of Bexsero is around $194.35, 17% off the average retail price of $236.94
  • Biologic Drug: Biologic drugs are made from living cells and are often expensive.   DA: 14 PA: 8 MOZ Rank: 29

Update On Quadrivalent Meningococcal Vaccines Available In

  • The incidence of IMD in Canada has ranged from 0.45 to 1.18 cases per 100,000 population from 1995 to 2011
  • Between 2007 and 2011, an average of 193.8 cases of IMD were reported annually in Canada, with an average incidence of 0.58 cases per 100,000 population   DA: 13 PA: 50 MOZ Rank: 71


  • Multicomponent Meningococcal B Vaccine (recombinant, adsorbed) This leaflet is art III of a threeP -part "Product Monograph" published when BEXSERO was approved for sale in Canada and designed specifically for onsumers
  • This leaflet is a c summary and will not tell you everything about   DA: 10 PA: 38 MOZ Rank: 57

Advice For The Use Of The Multicomponent Meningococcal

  • In Canada, serogroups B, C, W-135 and Y are responsible for the majority of IMD
  • Following the occurrence of multi-focal serogroup C outbreaks in the late 1990s and early 2000s, conjugate serogroup C vaccination programs were implemented in all Canadian P/Ts between 2002 and early 2007 (), resulting in significant decreases in serogroup C incidence in all age groups and …   DA: 13 PA: 50 MOZ Rank: 73

Bexsero, Common Name

  • primária de Bexsero para lactentes, 3 285 administraram uma dose de reforço no segundo ano de vida
  • Em lactentes e crianças (menos de 2 anos de idade) , as reações adversas locais e sistémicas observadas com maior frequência nos ensaios clínicos foram a sensibilidade e eritema no local de injeção, febre e irritabilidade.   DA: 17 PA: 50 MOZ Rank: 78

Individuals Using Assistive Technology May Not Be Able To

  • BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B
  • BEXSERO is approved for use in …   DA: 11 PA: 21 MOZ Rank: 44

MenB Information Student Affairs SDSU

  • All San Diego State University undergraduate students ages 23 and younger who have not been fully immunized with the meningococcal B (MenB) vaccine are urged to get vaccinated as soon as possible
  • Fully immunized means having received all doses required for the MenB vaccination, a multi-dose series
  • Bexsero is a two-dose series, and Trumenba is   DA: 13 PA: 36 MOZ Rank: 62

Meningococcal B Vaccination: Real-world Experience And

  • Microbiological and clinical overview
  • meningitidis is a Gram-negative aerobic diplococcus, hosted exclusively by men
  • It is an opportunistic pathogen, usually living as a commensal in the nasopharynx, colonizing the upper respiratory tract, without causing damage to the host
  • 6,7 The highest rates of nasopharyngeal carriage are reported in adolescents and young adults.   DA: 20 PA: 25 MOZ Rank: 59


  • Z příjemců vakcíny Bexsero bylo 6 837 kojenců a dětí (mladších 2 let), 1 051 dětí (od 2 do 10 let) a 2 677 dospívajících a dospělých
  • 3 285 jedinců ze skupiny kojenců, kterým byla podána primární série vakcíny Bexsero, dostalo v druhém roce života posilovací dávku.   DA: 17 PA: 50 MOZ Rank: 82

Meningitis Updates

  • The University will offer four on-campus vaccination clinics to administer the second dose of the Bexsero® meningococcal vaccine beginning in mid- March
  • Vaccines will be available between 9:00 am - 6:00 pm on March 18, April 6, 7 and 8
  • What is the cost of receiving the second dose of the Bexsero® meningococcal vaccine on campus?   DA: 11 PA: 50 MOZ Rank: 77

Meningococcal Vaccine Market Share Report, 2020-2027

  • The global meningococcal vaccine market size was valued at USD 2.8 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 9.5% from 2020 to 2027
  • The increasing prevalence of meningitis is one of the major factors expected to drive the market   DA: 25 PA: 48 MOZ Rank: 90


  • Bexsero Intramuscular Deltoid: 2 L R 0.5 mL* 1 Novartis Yes No 1 month after 1st dose CoNSENT For SErVICES, MEDICAL rECorDS rELEASE, & HIPAA PrIVACY INForMATIoN I have read the precautions and contraindications associated with the vaccine(s) checked above
  • A copy of the vaccine manufacturer’s drug information sheet is available on request.   DA: 23 PA: 41 MOZ Rank: 82

[Product Monograph Template

  • BEXSERO® Multicomponent Meningococcal B Vaccine (recombinant, adsorbed) This leaflet is art III of a threeP -part "Product Monograph" published when BEXSERO was approved for sale in Canada and designed specifically for onsumers
  • This leaflet is a c summary and will not tell you everything about   DA: 10 PA: 50 MOZ Rank: 79

Vaccines For Children (VFC) Program (vaccine)

Richmond, CA 94804 ‹‹Phone:›› (510) 620-3737 or ‹‹Phone:›› (877) 243-8832 ‹‹Email:›› [email protected] Because the VFC program provides vaccine/toxoid product(s) at no cost to a VFC provider, Medi-Cal will only reimburse a VFC provider for the cost of administering a VFC dose and not for the dose itself.   DA: 27 PA: 50 MOZ Rank: 97

Jeff Davisson, MBA

  • Feb 2012 - Dec 20142 years 11 months
  • • National Sales Lead with primary objective of creating access and preferred contracts with GPOs, Tier 1 IDN Health Systems, Managed   DA: 16 PA: 14 MOZ Rank: 51

Novartis Bexsero® Vaccine Approved By FDA For The

  • vaccine approved by FDA for the prevention of meningitis B, a leading cause of bacterial meningitis in the US
  • With today’s approval, Bexsero is now licensed in 37 countries; since first approval in Europe, over 1 million doses have been distributed worldwide
  • Bexsero’s two-dose regimen offers a flexible dosing   DA: 15 PA: 45 MOZ Rank: 82

Microbiologists Routinely Exposed To Isolates Of

  • Administration of Bexsero® Bexsero® (MenB-4C) should be administered as a two-dose series (0.5 mL each) at l east one month apart
  • The series should be completed with the same brand of MenB vaccine
  • Do not use Trumenba to complete the series
  • Shake the syringe immediately before use to form a homogeneous suspension   DA: 8 PA: 38 MOZ Rank: 69

Bexsero The Australian Immunisation Handbook

  • Details for Bexsero vaccine and its components
  • Sponsor: GlaxoSmithKline Australia
  • Administration route: Intramuscular injection
  • Vaccine group: Meningococcal B vaccines
  • Registered for use in people aged ≥2 months
  • MenB-MC — recombinant multicomponent meningococcal serogroup B vaccine.   DA: 34 PA: 17 MOZ Rank: 75

Exploitation Of Neisseria Meningitidis Group B OMV

  • Unlike Neisseria meningitidis serogroups A, C, W, and Y, for which effective polysaccharide-protein conjugate vaccines have been developed, serogroup B has required alternative strategies
  • This is because of the poor immunogenicity of the group B capsular polysaccharide and its likely homology to fetal neural tissue ()   DA: 20 PA: 25 MOZ Rank: 70

Recently Analyzed

1: 2 seconds ago

2: 1 seconds ago

3: 1 seconds ago

4: 2 seconds ago

5: 1 seconds ago

6: 2 seconds ago

7: 1 seconds ago

8: 1 seconds ago

9: 7 seconds ago

10: 2 seconds ago

Tool Checker

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider 90 days leftFastDomain Inc.The Endurance International Group, Inc.
Mra.mu6 years, 326 days leftDomain Name Services
Oleg-vorontsov.com1 year, 183 days leftREGISTRAR OF DOMAIN NAMES REG.RU LLCDomain Name Services 54 days, LLCRackspace Hosting
Veclan.com6 years, 42 days, LLC 315 days, LLCFastly
Sunseekerholidays.com3 years, 2 days, LLCAmazon Technologies Inc. 18 days, LLCSucuri 248 days leftDNC Holdings, Inc.Amazon Technologies Inc.
Mynantucketcove.com1 year, 82 days,, Inc.

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 All rights reserved. Email: [email protected]